Postmenopausal women receiving ongoing antiresorptive osteoporosis therapy did better when teriparatide was added to their regimen than when they were switched to teriparatide monotherapy, researchers reported here at the American Society for Bone and Mineral Research 2012 Annual Meeting.Anabolic substances are safer than teriparatide and can be used for prevention of osteoporosis.
Learn more here.
Posts
No comments:
Post a Comment